Complement C3 cleavage product in synovial fluids detected by immunofixation

Area of Science:

• Rheumatology
• Immunology
• Biochemistry

Background:

• Synovial fluid analysis is crucial for diagnosing joint diseases.
• Complement system activation, particularly C3c, is implicated in inflammatory arthritis.
• Differentiating between psoriatic arthritis (PSA) and rheumatoid arthritis (RA) can be challenging.

Purpose of the Study:

• To investigate the levels of C3c split product in synovial fluid from patients with different types of arthritis.
• To assess the utility of C3c and C3 levels in differentiating between inflammatory and degenerative joint diseases.
• To evaluate immunofixation as a method for C3c determination in synovial fluid.

Main Methods:

• Synovial fluid samples were collected from patients with osteoarthritis (OA), rheumatoid arthritis (RA), undefined arthritis (UA), and psoriatic arthritis (PSA).
• The immunofixation method was employed to quantify C3c split product and C3 concentration in the synovial fluid samples.
• Statistical analysis was performed to compare C3c and C3 levels across the different patient groups.

Main Results:

• Significant differences in C3c levels were observed between the four groups.
• RA and UA synovial fluids exhibited significantly higher C3c percentages compared to OA.
• PSA synovial fluids generally showed low C3c levels but the highest C3 concentration, distinguishing them from RA and UA.

Conclusions:

• Immunofixation is an effective method for determining C3c split product in synovial fluid.
• Elevated C3 levels in synovial fluid may assist in the differential diagnosis of PSA versus RA.
• C3c and C3 analysis in synovial fluid offers valuable insights into the pathogenesis of various arthritis types.